P01.057  Effects of tumor treating fields on health-related quality of life (HRQoL) in newly diagnosed glioblastoma: An exploratory analysis of the EF-14 randomized phase III trial

QLIF-25. EFFECT OF TUMOR TREATING FIELDS (TTFIELDS) ON HEALTH-RELATED QUALITY OF LIFE (HRQoL) IN NEWLY DIAGNOSED GLIOBLASTOMA. RESULTS OF THE EF-14 RANDOMIZED PHASE III TRIAL

Neuro-Oncology ◽

10.1093/neuonc/nox168.834 ◽

2017 ◽

Vol 19 (suppl_6) ◽

pp. vi206-vi206

Author(s):

Martin J B Taphoorn ◽

Linda Dirven ◽

Sophie Taillibert ◽

Jerôme Honnorat ◽

Thomas Chen ◽

...

Keyword(s):

Quality Of Life ◽

Phase Iii ◽

Newly Diagnosed ◽

Health Related Quality ◽

Phase Iii Trial ◽

Tumor Treating Fields ◽

Related Quality ◽

Health Related ◽

Effects of Tumor Treating Fields (TTFields) on Health-Related Quality of Life (HRQOL) in Newly Diagnosed Glioblastoma: An Exploratory Analysis of the EF-14 Randomized Phase III Trial

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2018.07.036 ◽

2018 ◽

Vol 102 (3) ◽

pp. S170-S171 ◽

Cited By ~ 1

Author(s):

S.A. Toms

Keyword(s):

Quality Of Life ◽

Phase Iii ◽

Newly Diagnosed ◽

Health Related Quality ◽

Phase Iii Trial ◽

Tumor Treating Fields ◽

Related Quality ◽

Health Related ◽

QOLP-01. EFFECTS OF TUMOR TREATING FIELDS ON HEALTH-RELATED QUALITY OF LIFE (HRQoL) IN NEWLY DIAGNOSED GLIOBLASTOMA: AN EXPLORATORY ANALYSIS OF THE EF-14 RANDOMIZED PHASE III TRIAL

Neuro-Oncology ◽

10.1093/neuonc/noy148.887 ◽

2018 ◽

Vol 20 (suppl_6) ◽

pp. vi214-vi214

Author(s):

Tobias Walbert ◽

Gitit Lavy-Shahaf

Keyword(s):

Quality Of Life ◽

Phase Iii ◽

Newly Diagnosed ◽

Health Related Quality ◽

Phase Iii Trial ◽

Tumor Treating Fields ◽

Related Quality ◽

Health Related ◽

Health-related quality of life, cognitive screening, and functional status in a randomized phase III trial (EF-14) of tumor treating fields with temozolomide compared to temozolomide alone in newly diagnosed glioblastoma

Journal of Neuro-Oncology ◽

10.1007/s11060-017-2601-y ◽

2017 ◽

Vol 135 (3) ◽

pp. 545-552 ◽

Cited By ~ 16

Author(s):

Jay-Jiguang Zhu ◽

◽

Petya Demireva ◽

Andrew A. Kanner ◽

Susan Pannullo ◽

...

Keyword(s):

Phase Iii ◽

Newly Diagnosed ◽

Cognitive Screening ◽

Health Related Quality ◽

Phase Iii Trial ◽

Tumor Treating Fields ◽

Related Quality ◽

Health Related ◽

Faculty Opinions recommendation of Lenalidomide, melphalan, and prednisone, followed by lenalidomide maintenance, improves health-related quality of life in newly diagnosed multiple myeloma patients aged 65 years or older: results of a randomized phase III trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717969674.793470152 ◽

2013 ◽

Author(s):

Christopher Steer

Keyword(s):

Quality Of Life ◽

Multiple Myeloma ◽

Phase Iii ◽

Newly Diagnosed ◽

Health Related Quality ◽

Phase Iii Trial ◽

Related Quality ◽

Influence of Treatment With Tumor-Treating Fields on Health-Related Quality of Life of Patients With Newly Diagnosed Glioblastoma

JAMA Oncology ◽

10.1001/jamaoncol.2017.5082 ◽

2018 ◽

Vol 4 (4) ◽

pp. 495 ◽

Cited By ~ 52

Author(s):

Martin J. B. Taphoorn ◽

Linda Dirven ◽

Andrew A. Kanner ◽

Gitit Lavy-Shahaf ◽

Uri Weinberg ◽

...

Keyword(s):

Quality Of Life ◽

Newly Diagnosed ◽

Health Related Quality ◽

Tumor Treating Fields ◽

Related Quality ◽

Health Related ◽

Abstract CT100: Tumor treating fields (TTFields) on health-related quality of life (HRQoL) in ndGBM: An exploratory analysis of the EF-14 phase III trial

10.1158/1538-7445.am2018-ct100 ◽

2018 ◽

Author(s):

Tobias Walbert ◽

Gitit Lavy-Shahaf ◽

Steven A Toms ◽

Santosh Kesari

Keyword(s):

Quality Of Life ◽

Exploratory Analysis ◽

Phase Iii ◽

Health Related Quality ◽

Phase Iii Trial ◽

Tumor Treating Fields ◽

Related Quality ◽

Lenalidomide, melphalan, and prednisone, followed by lenalidomide maintenance, improves health-related quality of life in newly diagnosed multiple myeloma patients aged 65 years or older: results of a randomized phase III trial

Haematologica ◽

10.3324/haematol.2012.074534 ◽

2012 ◽

Vol 98 (5) ◽

pp. 784-788 ◽

Cited By ~ 45

Author(s):

M. A. Dimopoulos ◽

M. Delforge ◽

R. Hajek ◽

M. Kropff ◽

M. T. Petrucci ◽

...

Keyword(s):

Quality Of Life ◽

Multiple Myeloma ◽

Phase Iii ◽

Newly Diagnosed ◽

Health Related Quality ◽

Phase Iii Trial ◽

Related Quality ◽

Health-related quality of life in patients with advanced renal cell carcinoma receiving pazopanib or placebo in a randomised phase III trial

European Journal of Cancer ◽

10.1016/j.ejca.2011.05.017 ◽

2012 ◽

Vol 48 (3) ◽

pp. 311-323 ◽

Cited By ~ 30

Author(s):

D. Cella ◽

A.S. Pickard ◽

M.S. Duh ◽

A. Guerin ◽

N. Mishagina ◽

...

Keyword(s):

Quality Of Life ◽

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Renal Cell ◽

Phase Iii ◽

Health Related Quality ◽

Phase Iii Trial ◽

Related Quality ◽

861 EFFECTS OF SUNITINIB VERSUS INTERFERON-ALFA IN HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC): RESULTS FROM A RANDOMIZED MULTINATIONAL PHASE III TRIAL

European Urology Supplements ◽

10.1016/s1569-9056(07)60856-2 ◽

2007 ◽

Vol 6 (2) ◽

pp. 238 ◽

Cited By ~ 3

Author(s):

D. Cella ◽

J.Z. Li ◽

J.C. Cappelleri ◽

A. Bushmakin ◽

S.T. Kim ◽

...

Keyword(s):

Quality Of Life ◽

Renal Cell Carcinoma ◽

Renal Cell ◽

Interferon Alfa ◽

Phase Iii ◽

Health Related Quality ◽

Phase Iii Trial ◽

Related Quality ◽